Not Signed In - Data Show Treatment With Remicade Reduced Hospitalizations For Ulcerative Colitis Patients By Half
Sat, 28 Oct 2006 12:00 AM EST
... Patients with ulcerative colitis (UC) treated with REMICADE® (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year compared with placebo, according to an analysis of long-term data from a Phase 3 clinical trial (Active Ulcerative Colitis Trial 1, ACT 1) presented at the American College of Gastroenterology (ACG) meeting. [click link for full article] ...
Related Topics
- Ulcerative Colitis
- Infliximab
- Colitis
- Data & Statistics
- Data Analysis
- Seizures (in about half of patients)
- Crohn's Disease
- National Data
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Gingivitis
- Collagenous Colitis
- Ankylosing Spondylitis
- Mining
- Mesalamine Oral
- Frostbite
- Lymphocytic Colitis
- Reduced intellect (sometimes)
- Reduced life span
- Reduced lung function
- Reduced communication skills (sometimes)
email this page
print this page
bookmark this page
feedback on this page
